| Literature DB >> 22754500 |
Anirban Paul1, Ying Cai, Gurinder S Atwal, Z Josh Huang.
Abstract
The assembly of neural circuits involves multiple sequential steps such as the specification of cell-types, their migration to proper brain locations, morphological and physiological differentiation, and the formation and maturation of synaptic connections. This intricate and often prolonged process is guided by elaborate genetic mechanisms that regulate each step. Evidence from numerous systems suggests that each cell-type, once specified, is endowed with a genetic program that unfolds in response to, and is regulated by, extrinsic signals, including cell-cell and synaptic interactions. To a large extent, the execution of this intrinsic program is achieved by the expression of specific sets of genes that support distinct developmental processes. Therefore, a comprehensive analysis of the developmental progression of gene expression in synaptic partners of neurons may provide a basis for exploring the genetic mechanisms regulating circuit assembly. Here we examined the developmental gene expression profiles of well-defined cell-types in a stereotyped microcircuit of the cerebellar cortex. We found that the transcriptomes of Purkinje cell and stellate/basket cells are highly dynamic throughout postnatal development. We revealed "phasic expression" of transcription factors, ion channels, receptors, cell adhesion molecules, gap junction proteins, and identified distinct molecular pathways that might contribute to sequential steps of cerebellar inhibitory circuit formation. We further revealed a correlation between genomic clustering and developmental co-expression of hundreds of transcripts, suggesting the involvement of chromatin level gene regulation during circuit formation.Entities:
Keywords: GABAergic; Purkinje cell; cerebellum; circuit assembly; development; gene expression; microcircuit; stellate basket cell
Year: 2012 PMID: 22754500 PMCID: PMC3385560 DOI: 10.3389/fncir.2012.00037
Source DB: PubMed Journal: Front Neural Circuits ISSN: 1662-5110 Impact factor: 3.492
Figure 1Cell-type and developmental stage-specific gene expression profiles in PC and S/BC. (A) Schematic representation of the anatomical changes during cerebellar development with emphasis on the postnatal stages. (B-D) PCA on all samples. Transcripts that changed significantly (SD > 1 of mean, p < 0.05) across all time points can clearly segregate PCs (blue) and S/BCs (red) (B). PCA based on all postsynaptic protein transcripts (C), encoding membrane proteins such as ion channels, cell adhesion molecules, and cell-surface ligand receptors; GABAergic transcripts (D) can segregate PCs and S/BCs, Non-specific B-cell activation transcripts (E), Blood glycolipid biosynthesis (F), and Glia expressed transcripts (G) fails to segregate the samples according to cell-types. (H–J) Cross-correlation analysis across all samples captures several developmental epochs in each cell-type. Transcription factor transcripts parse the PC into two distinct P3–P7 and P14–P56 epochs. S/BCs are also subdivided into P14–35 and P56 (H). Cell adhesion molecules divides the PC into two broad groups P3–P7 and P14–P56 and further subdivides the later into 3 epochs (P14–P21, P28–P35, and P56). S/BCs are also subdivided into 3 epochs P14–P21, P28–P35, and P56 (I). GABAergic transcripts subdivide the PCs into three epochs P3–P7, P14–P21, and P28–P56. S/BCs are roughly split into 2 classes P14–P21 and P28–P56. GABAergic transcripts comprised of all murine GABA receptors and transporters (J).
List of RNA .
| Primer name | Sequence 5′ > 3′ |
|---|---|
| Pvalb(AP)-F | GGATGTCGATGACAGACGTG |
| Pvalb(AP)-R | TTGTTTCTCCAGCATTTCCA |
| Pvalb(AP)-T7-R | taatacgactcactatagggTTGTTTCTCCAGCATTTCCA |
| Pvalb(AP)-T3-F | aattaaccctcactaaagggGGATGTCGATGACAGACGTG |
| Lypd6-F | TGACCATGGGAAGTTATCTGTG |
| Lypd6-R | AAGTCAGGCCTAGAGGTTTTCC |
| Lypd6-T3-F | aattaaccctcactaaagggTGACCATGGGAAGTTATCTGTG |
| Lypd6-T7-R | taatacgactcactatagggAAGTCAGGCCTAGAGGTTTTCC |
| ACAM-F | GCTCATTTTCCTCCTGATATGG |
| ACAM-R | CTTCTTGACTGTGGTGACTTGC |
| ACAM-T7-R | taatacgactcactatagggCTTCTTGACTGTGGTGACTTGC |
| ACAM-T3-F | aattaaccctcactaaagggGCTCATTTTCCTCCTGATATGG |
| Kirrel3-F | GCCTCCTCTTCCCACCAT |
| Kirrel3-R | AGGAAGGGAGAACACGGG |
| Kirrel3-T7-R | taatacgactcactatagggAGGAAGGGAGAACACGGG |
| Kirrel3-T3-F | aattaaccctcactaaagggGCCTCCTCTTCCCACCAT |
| Lgi3-F | CAGTGTCCAGGCTCTCTATGTG |
| Lgi3-R | CTCAGGCTGTCTCAGGATTCTT |
| Lgi3-T7-R | taatacgactcactatagggCTCAGGCTGTCTCAGGATTCTT |
| Lgi3-T3-F | aattaaccctcactaaagggCAGTGTCCAGGCTCTCTATGTG |
| Erbb2ip-F | GGATCCAGAACTTGGATTTAGC |
| Erbb2ip-R | TAACAAGGACACCGCTTGC |
| Erbb2ip-T7-R | taatacgactcactatagggTAACAAGGACACCGCTTGC |
| Erbb2ip-T3-F | aattaaccctcactaaagggGGATCCAGAACTTGGATTTAGC |
| Kirrel1-F | GAAGGCGAGCGTGTCATT |
| Kirrel1-R | CGATTCACCGTCTCCACC |
| Kirrel1-T7-R | taatacgactcactatagggCGATTCACCGTCTCCACC |
| Kirrel1-T3-F | aattaaccctcactaaagggGAAGGCGAGCGTGTCATT |
| Phyhip-F | CTTCTGTCGTGACCGGCT |
| Phyhip-R | GGAGGGATGGACGGTTCT |
| Phyhip-T7-R | taatacgactcactatagggGGAGGGATGGACGGTTCT |
| Phyhip-T3-F | aattaaccctcactaaagggCTTCTGTCGTGACCGGCT |
| Lphn3-F | CCGAGAACACAGTCATGTGG |
| Lphn3-R | TCCACTCTGTGAGGGAGCTT |
| Lphn3-T7-R | taatacgactcactatagggTCCACTCTGTGAGGGAGCTT |
| Lphn3-T3-F | aattaaccctcactaaagggCCGAGAACACAGTCATGTGG |
| Arhgap21-F | AAGAAGTCTGCTCGCTTCAAGT |
| Arhgap21-R | GGCTAGACCCAGCTTAAAGTCA |
| Arhgap21-T7-R | taatacgactcactatagggGGCTAGACCCAGCTTAAAGTCA |
| Arhgap21-T3-F | aattaaccctcactaaagggAAGAAGTCTGCTCGCTTCAAGT |
Figure 2Pathway enrichment analysis of developmentally co-regulated transcripts in PC and S/BCs. (A) Pathways enriched at specific developmental stages in PCs (left) and S/BCs (right). Each colored box represents significant p-values of the associated pathway across the developmental stages that are either upregulated (red), down-regulated (blue), or non-significant enrichment (gray). (B) Comparison between PC and S/BCs shows delayed elevation of pathways involved in early postnatal development in S/BCs.
Figure 3Co-expressed transcripts are often co-localized on the genome. (A) Distribution of total number of co-expressed and co-localized transcript between PC and S/BCs during development. (B) Frequency distribution of the different co-localized clusters. (C) Size distribution of different co-localized clusters in PC and S/BCs. Average size of all clusters across all time points for PC and S/BCs shown in inset. (D–G) Representative chromosomal distribution of co-localized and co-expressed transcripts at specific developmental stages. The region harboring co-expressed and co-localized clusters are depicted as black bar spanning across the starting and ending ORFs in UCSC genome browser (see UCSC track files in BED format Table S1 in Supplementary Material for PC and Table S2 in Supplementary Material for S/BC). Certain cluster groups are stable between developmental stages P3 and P7 in PCs [(D), see also Table A1 in Appendix]. Co-localized clusters can re-emerge in late-developmental stages as shown in PC cell by comparing the P3 and P7 time points with P56 (E). Representative common clusters across cell-types during early postnatal developmental stage (F). Few such clusters are common between cell-types in late-adult stages suggesting the maintenance of a “locked-in” differentiated state (G).
Pathway and gene ontology terms enriched in PC, P3-P7 stable clusters.
| Category | Term | Count | % | Genes | List total | Pop hits | Pop total | Fold enrichment | Bonferroni | Benjamini | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KEGG_PATHWAY | mmu03010:Ribosome | 14 | 3.357 | 8.09E−08 | RPL26, RPL35, RPL27, RPL23A, RPS18, RPS27, RPL23, RPS29, RPL31, RPL8, RPS13, RPL37A, RPL12, RPS11 | 132 | 89 | 5738 | 6.84 | 9.79E−06 | 9.79E−06 |
| KEGG_PATHWAY | mmu00030:Pentose phosphate pathway | 5 | 1.199 | 2.63E−03 | ALDOC, PGD, PFKP, TKT, PRPS1 | 132 | 26 | 5738 | 8.36 | 2.73E−01 | 1.47E−01 |
| KEGG_PATHWAY | mmu04810:Regulation of actin cytoskeleton | 12 | 2.878 | 1.04E−02 | ACTB, ENAH, PDGFA, PAK3, SOS1, SSH2, TMSB4X, ITGA3, ITGB2, DIAP3, MYH10, APC | 132 | 217 | 5738 | 2.40 | 7.16E−01 | 3.43E−01 |
| GOTERM_BP_FAT | GO:0007010 ∼ cytoskeleton organization | 19 | 4.556 | 2.89E−04 | ABLIM2, MTSS1, ENAH, CAP2, PDGFA, GAS7, RHOU, SHH, THY1, SS18, NDEL1, EPB4.1L1, SGCG, EPS8, TMSB4X, STMN1, DIAP3, SYNPO, MYH10 | 297 | 326 | 13588 | 2.67 | 3.88E−01 | 3.88E−01 |
| GOTERM_BP_FAT | GO:0030001 ∼ metal ion transport | 22 | 5.276 | 6.94E−04 | KCNMB4, SCN1A, SCN1B, SCN3A, SCN2B, TMEM38A, SLC24A5, ATP1A1, CACNB3, SFXN1, ANXA6, KCTD9, ATP2B2, P2RX4, ATP2B3, KCNT1, CACNA1G, KCTD15, STEAP2, CACNA1D, KCNG4, CACNA1B | 297 | 442 | 13588 | 2.28 | 6.92E−01 | 4.45E−01 |
| GOTERM_BP_FAT | GO:0006812 ∼ cation transport | 24 | 5.755 | 9.14E−04 | KCNMB4, SCN1A, SCN1B, SCN2B, SCN3A, TMEM38A, SLC24A5, ATP1A1, CACNB3, SFXN1, ANXA6, KCTD9, ATP2B2, P2RX4, ATP2B3, KCNT1, ATP5S, SLC41A3, CACNA1G, KCTD15, STEAP2, CACNA1D, KCNG4, CACNA1B | 297 | 515 | 13588 | 2.13 | 7.88E−01 | 4.04E−01 |
| GOTERM_BP_FAT | GO:0048666 ∼ neuron development | 16 | 3.837 | 1.89E−03 | KLF7, ENAH, VAX2, EN2, PRKG1, GAS7, SHH, CTNNA2, THY1, ATP2B2, NDEL1, ANK3, STMN1, SS18L1, APC, MYH10 | 297 | 292 | 13588 | 2.51 | 9.60E−01 | 5.52E−01 |
| GOTERM_BP_FAT | GO:0015674 ∼ di-, tri-valent inorganic cation transport | 11 | 2.638 | 2.78E−03 | ANXA6, P2RX4, ATP2B2, ATP2B3, CACNA1G, SLC24A5, CACNB3, SFXN1, STEAP2, CACNA1D, CACNA1B | 297 | 161 | 13588 | 3.13 | 9.91E−01 | 6.12E−01 |
| GOTERM_BP_FAT | GO:0031175 ∼ neuron projection development | 13 | 3.118 | 3.01E−03 | ENAH, KLF7, VAX2, PRKG1, GAS7, SHH, CTNNA2, NDEL1, ANK3, STMN1, SS18L1, MYH10, APC | 297 | 218 | 13588 | 2.73 | 9.94E−01 | 5.74E−01 |
| GOTERM_BP_FAT | GO:0008283 ∼ cell proliferation | 14 | 3.357 | 3.02E−03 | WNT5A, PDGFA, NASP, CREBBP, ITGB2, PRKCD, SHH, NR2C2, HDGFRP3, ANXA7, NDEL1, NCOR2, CUL1, MYH10 | 297 | 247 | 13588 | 2.59 | 9.94E−01 | 5.20E−01 |
| GOTERM_BP_FAT | GO:0030030 ∼ cell projection organization | 16 | 3.837 | 4.35E−03 | MTSS1, KLF7, ENAH, PDGFA, VAX2, PRKG1, GAS7, SHH, CTNNA2, ATP2B2, NDEL1, ANK3, STMN1, SS18L1, APC, MYH10 | 297 | 319 | 13588 | 2.29 | 9.99E−01 | 6.04E−01 |
| GOTERM_BP_FAT | GO:0006816 ∼ calcium ion transport | 9 | 2.158 | 4.96E−03 | ANXA6, P2RX4, ATP2B2, ATP2B3, CACNA1G, SLC24A5, CACNB3, CACNA1D, CACNA1B | 297 | 121 | 13588 | 3.40 | 1.00E+00 | 6.09E−01 |
| GOTERM_BP_FAT | GO:0048812 ∼ neuron projection morphogenesis | 11 | 2.638 | 5.24E−03 | KLF7, ENAH, NDEL1, ANK3, VAX2, STMN1, GAS7, SHH, MYH10, CTNNA2, APC | 297 | 176 | 13588 | 2.86 | 1.00E+00 | 5.90E−01 |
| GOTERM_CC_FAT | GO:0034703 ∼ cation channel complex | 10 | 2.398 | 3.26E−04 | KCTD9, KCNMB4, SCN1A, SCN3A, CACNA1G, KCTD15, CACNB3, CACNA1D, KCNG4, CACNA1B | 288 | 95 | 12504 | 4.57 | 9.26E−02 | 9.26E−02 |
| GOTERM_CC_FAT | GO:0005840 ∼ ribosome | 14 | 3.357 | 4.89E−04 | RPL26, RPL35, RPL27, RPL23A, RPS18, RPS27, RPL23, RPS29, RPL31, RPL8, RPS13, RPL37A, RPL12, RPS11 | 288 | 192 | 12504 | 3.17 | 1.36E−01 | 7.03E−02 |
| GOTERM_CC_FAT | GO:0043232 ∼ intracellular non-membrane-bounded organelle | 63 | 15.11 | 2.73E−03 | MTSS1, ENAH, PPP2R5A, CEP76, MLPH, TTLL7, TTLL1, RHOU, 2310008H09RIK, LATS2, CITED2, MTAP6, BRD4, RPL12, SS18L1, ANKS1B, NOL7, TANC1, CTNNA2, SS18, RPS18, RND1, NDEL1, SGCG, SPAG5, FNBP1L, RPS13, TMSB4X, STMN1, RPS11, ABLIM2, HMGB3, YPEL4, SSH2, RPL35, CORO2B, RPS27, RPS29, RPL31, SOS1, RPL8, APC, SYNPO, ACTB, ZFP346, CENPO, NF2, CREBBP, RPL26, RPL27, RPL23A, COTL1, GAS7, MLF1IP, DOCK4, EPB4.1L1, EPS8, RPL23, RPL37A, H3F3B, FEZ1, CALM1, MYH10 | 288 | 1919 | 12504 | 1.43 | 5.57E−01 | 2.38E−01 |
| GOTERM_CC_FAT | GO:0043228 ∼ non-membrane-bounded organelle | 63 | 15.11 | 2.73E−03 | MTSS1, ENAH, PPP2R5A, CEP76, MLPH, TTLL7, TTLL1, RHOU, 2310008H09RIK, LATS2, CITED2, MTAP6, BRD4, RPL12, SS18L1, ANKS1B, NOL7, TANC1, CTNNA2, SS18, RPS18, RND1, NDEL1, SGCG, SPAG5, FNBP1L, RPS13, TMSB4X, STMN1, RPS11, ABLIM2, HMGB3, YPEL4, SSH2, RPL35, CORO2B, RPS27, RPS29, RPL31, SOS1, RPL8, APC, SYNPO, ACTB, ZFP346, CENPO, NF2, CREBBP, RPL26, RPL27, RPL23A, COTL1, GAS7, MLF1IP, DOCK4, EPB4.1L1, EPS8, RPL23, RPL37A, H3F3B, FEZ1, CALM1, MYH10 | 288 | 1919 | 12504 | 1.43 | 5.57E−01 | 2.38E−01 |
| GOTERM_CC_FAT | GO:0005912 ∼ adherens junction | 9 | 2.158 | 3.02E−03 | ENAH, NF2, PKP3, SSH2, LMO7, SSX2IP, CXADR, RHOU, CTNNA2 | 288 | 106 | 12504 | 3.69 | 5.94E−01 | 2.02E−01 |
| GOTERM_CC_FAT | GO:0034702 ∼ ion channel complex | 11 | 2.638 | 3.51E−03 | KCTD9, KCNMB4, SCN1A, SCN3A, CLIC6, CACNA1G, KCTD15, CACNB3, CACNA1D, KCNG4, CACNA1B | 288 | 158 | 12504 | 3.02 | 6.49E−01 | 1.89E−01 |
| GOTERM_CC_FAT | GO:0034704 ∼ calcium channel complex | 4 | 0.959 | 4.44E−03 | CACNA1G, CACNB3, CACNA1D, CACNA1B | 288 | 15 | 12504 | 11.58 | 7.34E−01 | 1.98E−01 |
| GOTERM_CC_FAT | GO:0005891 ∼ voltage-gated calcium channel complex | 4 | 0.959 | 4.44E−03 | CACNA1G, CACNB3, CACNA1D, CACNA1B | 288 | 15 | 12504 | 11.58 | 7.34E−01 | 1.98E−01 |
| GOTERM_CC_FAT | GO:0043025 ∼ cell soma | 9 | 2.158 | 5.51E−03 | ATP2B2, SCN1A, SOS1, NRSN2, PPT1, TTLL7, MYH10, SYNPO, CACNA1B | 288 | 117 | 12504 | 3.34 | 8.07E−01 | 2.10E−01 |
| GOTERM_CC_FAT | GO:0070161 ∼ anchoring junction | 9 | 2.158 | 7.40E−03 | ENAH, NF2, PKP3, SSH2, LMO7, SSX2IP, CXADR, RHOU, CTNNA2 | 288 | 123 | 12504 | 3.18 | 8.91E−01 | 2.42E−01 |
| GOTERM_MF_FAT | GO:0008092 ∼ cytoskeletal protein binding | 25 | 5.995 | 1.58E−05 | ABLIM2, MTSS1, ENAH, MLPH, SSH2, LMO7, CORO2B, PACSIN3, PACSIN2, MTAP6, SYNPO, APC, CAP2, NF2, COTL1, GAS7, GMFB, NDEL1, EPB4.1L1, SPAG5, TMSB4X, STMN1, DIAP3, MYH10, FEZ1 | 294 | 414 | 13288 | 2.73 | 7.31E−03 | 7.31E−03 |
| GOTERM_MF_FAT | GO:0003735 ∼ structural constituent of ribosome | 14 | 3.357 | 2.95E−05 | RPL26, RPL35, RPL27, RPL23A, RPS18, RPS27, RPL23, RPS29, RPL31, RPL8, RPS13, RPL37A, RPL12, RPS11 | 294 | 151 | 13288 | 4.19 | 1.36E−02 | 6.82E−03 |
| GOTERM_MF_FAT | GO:0046873 ∼ metal ion transmembrane transporter activity | 17 | 4.077 | 7.19E−04 | KCNMB4, SCN1A, SCN1B, SCN3A, SCN2B, TMEM38A, CACNB3, ATP2B2, P2RX4, KCTD9, ATP2B3, KCNT1, CACNA1G, KCTD15, CACNA1D, KCNG4, CACNA1B | 294 | 290 | 13288 | 2.65 | 2.84E−01 | 1.05E−01 |
| GOTERM_MF_FAT | GO:0005261 ∼ cation channel activity | 15 | 3.597 | 1.24E−03 | KCNMB4, SCN1A, SCN1B, SCN3A, SCN2B, TMEM38A, CACNB3, P2RX4, KCTD9, KCNT1, CACNA1G, KCTD15, CACNA1D, KCNG4, CACNA1B | 294 | 248 | 13288 | 2.73 | 4.38E−01 | 1.34E−01 |
| GOTERM_MF_FAT | GO:0022836 ∼ gated channel activity | 16 | 3.837 | 1.46E−03 | KCNMB4, SCN1A, SCN1B, SCN3A, SCN2B, TMEM38A, CACNB3, P2RX4, KCTD9, KCNT1, CLIC6, CACNA1G, KCTD15, CACNA1D, KCNG4, CACNA1B | 294 | 281 | 13288 | 2.57 | 4.91E−01 | 1.26E−01 |
| GOTERM_MF_FAT | GO:0005244 ∼ voltage-gated ion channel activity | 12 | 2.878 | 2.08E−03 | KCTD9, SCN1A, SCN1B, SCN3A, SCN2B, CLIC6, CACNA1G, KCTD15, CACNB3, CACNA1D, KCNG4, CACNA1B | 294 | 179 | 13288 | 3.03 | 6.19E−01 | 1.49E−01 |
| GOTERM_MF_FAT | GO:0022832 ∼ voltage-gated channel activity | 12 | 2.878 | 2.08E−03 | KCTD9, SCN1A, SCN1B, SCN3A, SCN2B, CLIC6, CACNA1G, KCTD15, CACNB3, CACNA1D, KCNG4, CACNA1B | 294 | 179 | 13288 | 3.03 | 6.19E−01 | 1.49E−01 |
| GOTERM_MF_FAT | GO:0022843 ∼ voltage-gated cation channel activity | 10 | 2.398 | 2.10E−03 | KCTD9, SCN1A, SCN3A, SCN2B, CACNA1G, KCTD15, CACNB3, CACNA1D, KCNG4, CACNA1B | 294 | 128 | 13288 | 3.53 | 6.24E−01 | 1.30E−01 |
| GOTERM_MF_FAT | GO:0005216 ∼ ion channel activity | 17 | 4.077 | 4.71E−03 | KCNMB4, SCN1A, SCN1B, SCN3A, SCN2B, TMEM38A, CACNB3, FXYD6, P2RX4, KCTD9, KCNT1, CLIC6, CACNA1G, KCTD15, CACNA1D, KCNG4, CACNA1B | 294 | 349 | 13288 | 2.20 | 8.88E−01 | 2.39E−01 |
| GOTERM_MF_FAT | GO:0050839 ∼ cell adhesion molecule binding | 4 | 0.959 | 4.80E−03 | NPTN, ITGB2, NEO1, CTNNA2 | 294 | 16 | 13288 | 11.30 | 8.93E−01 | 2.20E−01 |
Figure 4Cell-type specific phasic temporal profiles of several classes of transcripts. (A1) Cell-type specific GABAergic transcripts between cell-types, (A2,A3) PC and SB individual temporal profiles are shown. (B1) Cell-type specific cell adhesion molecules (CAMs) transcripts, (B2,B3) PC and SB specific individual profiles are shown. (C) Cell-type specific expression of NMDA receptors, (D) AMPA receptors, (E) Calcium channels, and (F) Gap junction molecules.
Figure A2Representative RNA in-situs from Allen Brain mouse brain (only P56 time point available) images showing the PC specific expression of cell adhesion molecule transcripts, .
Figure A1Representative RNA in-situs from Allen Brain developing mouse brain images showing the expression of cell adhesion molecule transcripts, . Expression changes matched with microarray developmental profiles.
Figure A3Representative RNA in-situs from Allen Brain developing mouse brain images showing the expression of NMDA and AMPA transcripts; S/BC restricted . Expression changes matched with microarray developmental profiles. Grm3 signal is weaker than Golgi cells as has been reported in Ohishi et al. (1993).
Figure A4Representative RNA in-situs from Allen Brain mouse brain (only P56 time point available) images showing the PC specific expression of voltage-gated calcium channel transcripts, . Also showing the expression of gap junction proteins Gjd2 and Gjc1 in S/BC.
Figure 5Cell-type specific expression of TFs. (A) Phasic expression of TFs between PC and S/BCs. (B,C) Identification of cell-type specific TFs by promoter scanning of co-regulated transcripts during development. (B) Observed cell-type specific co-regulated transcripts at each time points in both PC and S/BCs. (C) Promoter scanning for binding motifs of temporally co-regulated transcripts correctly identifies S/BC and PC TFs that match with cell-type specific microarray data.
PSCAN results for PC and S/BC showing TF enriched among the co-expressed transcripts at P14 and P56 time points.
| Cell-type and age | TF name | Bonferonni | ||
|---|---|---|---|---|
| PCs at P14 | MIZF | 5.65792 | 6.11E−09 | 7.94E−07 |
| HIF1A:ARNT | 4.79104 | 7.31E−07 | 9.50E−05 | |
| PCs at P56 | ELK1 | 8.90068 | 1.37E−19 | 1.79E−17 |
| GABPA | 8.77248 | 4.42E−19 | 5.74E−17 | |
| MIZF | 5.97238 | 8.54E−10 | 1.11E−07 | |
| ARNT:AHR | 4.52425 | 2.61E−06 | 3.40E−04 | |
| S/BCs at P14 | EGR1 | 12.8264 | 2.19E−44 | 2.85E−42 |
| KLF4 | 11.5272 | 9.02E−36 | 1.17E−33 | |
| NFKB1 | 8.13968 | 4.59E−19 | 5.96E−17 | |
| PAX5 | 7.95113 | 2.31E−18 | 3.00E−16 | |
| CTCF | 7.437 | 2.19E−16 | 2.85E−14 | |
| E2F1 | 7.29049 | 8.92E−16 | 1.16E−13 | |
| ARNT | 6.35681 | 1.29E−12 | 1.68E−10 | |
| NHLH1 | 6.05526 | 1.98E−11 | 2.57E−09 | |
| TCFCP2L1 | 5.85053 | 8.88E−11 | 1.15E−08 | |
| RREB1 | 4.72247 | 1.15E−07 | 1.49E−05 | |
| MAFB | 4.37757 | 8.97E−07 | 1.17E−04 | |
| MYF | 4.24664 | 1.78E−06 | 2.32E−04 | |
| ELK4 | 4.21708 | 2.00E−06 | 2.59E−04 | |
| S/BCs at P56 | KLF4 | 5.64019 | 6.24E−09 | 8.12E−07 |
| SP1 | 5.46909 | 1.77E−08 | 2.30E−06 | |
| HIF1A:ARNT | 4.79591 | 6.37E−07 | 8.28E−05 | |
| EGR1 | 4.28222 | 7.55E−06 | 9.81E−04 | |
| TFAP2A | 4.60855 | 1.73E−06 | 2.25E−04 | |
| ZFX | 4.44252 | 3.70E−06 | 4.82E−04 |
Figure 6Expression of PC and S/BCs specific transcripts. (A) Heatmap showing novel cell-type specific transcripts and their developmental profiles. (B) Schematic diagram of the cerebellar and nissl stained cerebellum section indicating respective layers. (C–J) In situ hybridization panels of the novel S/BC transcripts validating the microarray data. Each panel shows two time points P21, P56, and control probes. Abbreviations: gcl, granule cell layer; ml, molecular layer; pcl, Purkinje cell layer; wm, white matter; M, medial; L, lateral.